Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 278.00 | |
5 mg | In stock | $ 695.00 | |
10 mg | In stock | $ 988.00 | |
25 mg | In stock | $ 1,470.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,670.00 |
Description | GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode. |
Molecular Weight | 584.71 |
Formula | C29H37FN6O4S |
CAS No. | 2125968-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (85.5 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK251 2125968-05-8 PI3K/Akt/mTOR signaling PI3K GSK 251 GSK-251 inhibitor inhibit